Bcl-2 antiapoptotic protein mediates verotoxin II-induced cell death: Possible association between Bcl-2 and tissue failure by E. coli O157:H7

Genes and Development

Volumn 14, Issue 14, 2000, Pages 1734-1740

  Suzuki, Atsushi ^a   Doi, Hirofumi ^b,c   Matsuzawa, Fumiko ^b   Aikawa, Sei Ichi ^b   Takiguchi, Kyoko ^b   Kawano, Hirokazu ^a   Hayashida, Midori ^a   Ohno, Susumu ^d  

^a DAIICHI SANKYO CO   (Japan)

^b FUJITSU LABORATORIES LTD   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Bcl 2; Cell death; Escherichia coli O157:H7 derived verotoxin II; Multiple tissue failure

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 2; VEROTOXIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI O157; GRAM NEGATIVE INFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; TARGET CELL;

AMINO ACID SEQUENCE; BACTERIAL TOXINS; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELL DEATH; CELL NUCLEUS; CELL SURVIVAL; DIMERIZATION; DNA, MITOCHONDRIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ESCHERICHIA COLI; HUMANS; MICROINJECTIONS; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2; SEQUENCE HOMOLOGY, AMINO ACID; SHIGA-LIKE TOXIN I; SHIGA-LIKE TOXIN II; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034661251     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Akao, Y., Otsuki, Y., Kataoka, S., Ito, Y., and Tsujimoto, Y. 1994. Multiple subcellular localization of bcl-2: Detection in nuclear outer membrane, endoplasmic reticulum, and mitochondrial membranes. Cancer Res. 54: 2468-2471.
2. Alnemri, E.S., Livingston, D.J., Nicholson, D.W., Salvesen, G., Thornbery, N.A., Wong, W.W., and Yuan, J. 1996. Human ICE/CED-3 protease nomenclature. Cell 87: 171.
3. Arab, S., Murakami, M., Dirks, P., Boyd, B., Hubbard, S.L., Lingwood, C.A., and Rutka, J.T. 1998. Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells. J. Neurooncol. 40: 137-150.
4. Boise, L.H., Gonzalez-Garcia, M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nunez, G., and Thompson, C.B. 1993. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608.
5. Brigotti, M., Carnicelli, D., Alvergna, P., Mazzaracchio, R., Sperti, S., and Montanaro, L. 1997. The RNA-N-plycosidase activity of Shiga-like toxin I: Kinetic parameters of the native and activated toxin. Toxicon 35: 1431-1437.
6. Chittenden, T., Flemington, C., Houghton, A.B., Ebb, R.G., Gallo, G.J., Elangovan, B., Chinnadurai, G., and Lutz, R.J. 1995. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14: 5589-5596.
7. Chittenden, T., Harrington, E.A., O'Connor, R., Flemington, C., Lutz, R.J., Evan, G.I., and Guild, B.C. 1996. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374: 733-736.
8. Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, S. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43-50.
9. Enari, M., Talanian, R.V., Wong, W.W., and Nagata, S. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380: 723-726.
10. Fleisher, S. and Kervina, M. 1974. Subcellular fractionation of rat liver. Methods Enzymol. 31: 6-41.
11. Gannon, V.P. and Gyles, C.L. 1990. Characteristics of the Shiga-like toxin produceed by Escherichia coli associated with porcine edema disease. Vet. Microbiol. 24: 89-100.
12. Guest, R. 1996. Four die in food poisoning outbreak in Japan. Br. Med. J. 313: 187.
13. Hasegawa, J., Kamada, S., Kamiike, W., Shimizu, S., Imazu, T., Matsuda, H., and Tsujimoto, Y. 1996. Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis. Cancer Res. 56: 1713-1718.
14. Kamada, S., Shimono, A., Shinto, Y., Tsujimura, T., Takahashi, T., Noda, T., Kitamura, Y., Kondoh, H., and Tsujimoto, Y. 1995. Bcl-2 deficiency in mice leads to pleiotropic abnormalities: Accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res. 55: 354-359.
15. LaCasse, E.G., Bray, M.R., Patterson, B., Lim, W.M., Perampalam, S., Radvanyl, L.G., Keating, A., Stewart, A.K., Buckstein, R., Sandhu, J.S., et al. 1999. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoetic stem cells: Implications for ex vivo tumor purging and autologous stem cell transplantation. Blood 94: 2901-2910.
16. Lazebnic, Y.A., Kaufmann, S.H., Desnoyers, S., Poirier, G.G., and Earnshaw, W.C. 1994. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347.
17. Mangeney, M., Lingwood, C.A., Taga, S., Caillou, B., Tursz, T., and Wiels, J. 1993. Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a plycolipid antigen. Cancer Res. 53: 5314-5319.
18. Nagata, S. 1997. Apoptosis by death factor. Cell 88: 355-365.
19. Nagata, S. and Golstein, P. 1995. The Fas death factor. Science 267: 1449-1456.
20. Nathan, R. 1997. American seeds suspected in Japanese food poisoning epidemic. Nat. Med. 3: 705-706.
21. Oltvai, Z.N., Milliman, C.L., and Korsmeyer, S.J. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619.
22. Paton, J.C. and Paton, A.W. 1998. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11: 450-479.
23. Sahara, S., Aoto, M., Eguchi, Y., Imamoto, N., Yoneda, Y., and Tsujimoto, Y. 1999. Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. Nature 401: 168-173.
24. Sandvig, K., Garred, O., and Van Deurs, B. 1997. Intracellular transport and processing of protein toxins produced by enteric bacteria. Adv. Exp. Med. Biol. 412: 225-232.
25. Seto, M., Jaeger, U., Hockett, R.D., Graninger, W., Bennett, S., Goldman, P., and Korsmeyer, S.J. 1988. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J. 7: 123-131.
26. Shimizu, S., Narita, M., and Tsujimoto, Y. 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483-487.
27. Suzuki, A., Tsutomi, Y., Akahane, K., Araki, T., and Miura, M. 1998. Resistance to Fas-mediated apoptosis: Activation of caspase 3 is regulated by cell cycle regulator p2IWAF1 and IAP gene family ILP. Oncogene 17: 931-940.
28. Suzuki, A., Tsutomi, Y., Yamamoto, N., Shibutani, T., and Akahane, K. 1999. Mitochondrial regulation of cell death:Mitochondria are essential for procaspase 3/p21 complex formation to resist Fas-mediated cell death. Mol. Cell. Biol. 19: 3842-3847.
29. Tesh, V.L., Burris, J.A., Owens, J.W., Gordon, V.W., Wadolkowski, E.A., O'Brien, A.D., and Samuel, J.E. 1993. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immunol. 61: 3392-3402.
30. Tsujimoto, Y. 1989. Stress-resistance conferred by high level of bcl-2 alpha protein in human B lymphoblastoid cell. Oncogene 4: 1331-1336.
31. Tsujimoto, Y., Yunis, J., Nowell, P.C., and Croce, C.M. 1984. Cloning of the chromosomal breakpoint of neoplastic B cells with the t(14; 18) chromosome translocation. Science 226: 1097-1099.
32. Tyrrell, G.J., Ramotar, K., Toye, B., Boyd, B., Lingwood, C.A., and Brunton, J.L. 1992. Alteration of the carbohydrate binding specificity of verotoxins from Galα 1-4Gal to GalNAcβ 1-3Galα 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit. Proc. Natl. Acad. Sci. 89: 524-528.
33. Van Setten, P.A., van Hinsbergh, V.W., Van den Heuvel, L.P., van der Velden, T.J., van den Kar, N.C., Krebbers, R.J., Karmali, M.A., and Monnens, L.A. 1997. Verotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: Evidence for two distinct mechanisms. J. Am. Soc. Nephrol. 8: 1877-1888.
34. Vaux, D.L., Cory, S., and Adams, J.M. 1988. Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442.
35. Veis, J.D., Sorenson, C.M., Shutter, J.R., and Korsmeyer, S.J. 1993. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75: 229-240.
36. Wang, K., Yin, X.M., Chao, D.T., Milliman, C.L., and Korsmeyer, S.J. 1996. BID: A novel BH3 domain-only death agonist. Genes & Dev. 10: 2859-2869.
37. Williams, G.T. and Smith, C.A. 1993. Molecular regulation of apoptosis: Genetic controls on cell death. Cell 74: 777-779.
38. Wyllie, A.H., Kerr, J.F.R., and Currie, A.R. 1980. Cell death: The significance of apoptosis. Int. Rev. Cytol. 68: 251-306.
39. Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., Peng, T.-I., Jones, D.P., and Wang, X. 1997. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275: 1129-1132.
40. Yin, X.M., Oltvai, Z.N., and Korsmeyer, S.J. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321-323.
41. Yonehara, S., Ishii, A., Yonehara, M. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down-regulated with the receptor of tumor necrosis factor. J. Exp. Med. 169: 1747-1756.
42. Zou, H., Henzel, W.J., Liu, X., Lutschg, A., and Wang, X. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413.